IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive ...

This article first appeared on GuruFocus. Icecure Medical Ltd (NASDAQ:ICCM) is set to release its Q4 2025 earnings on Mar 17, 2026. The consensus estimate for Q4 2025 revenue is $1.90 million, and the ...

IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to ...

Icecure Medical (NASDAQ: ICCM) stock is up 80%. ICCM stock has risen on the back of yet another report on how well the treatment works. We say yet another as the stock has long been volatile dependent ...

Detailed price information for Icecure Medical Ltd Ord (ICCM-Q) from The Globe and Mail including charting and trades.

ICECURE MEDICAL ($ICCM) posted quarterly earnings results on Wednesday, May 28th. The company reported earnings of -$0.06 per share, beating estimates of -$0.08 by $0 ...

IceCure Medical Ltd. Annual cash flow by MarketWatch. View ICCM net cash flow, operating cash flow, operating expenses and cash dividends.